title: Clinical review 51: Implications of the Diabetes Control and Complications Trial.
authors.affiliation: Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: R C
authors.initials: RC
authors.lastname: Eastman
authors.forename: C W
authors.initials: CW
authors.lastname: Siebert
authors.forename: M
authors.initials: M
authors.lastname: Harris
authors.forename: P
authors.initials: P
authors.lastname: Gorden
mesh_terms: D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D003929:Diabetic Neuropathies / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use
chemical_list: D007328:Insulin